Status:

RECRUITING

Post-Marketing Surveillance of Vliwazell® Prowound Dressing

Lead Sponsor:

Lohmann & Rauscher

Conditions:

Acute and Chronic Wounds

Eligibility:

All Genders

18+ years

Brief Summary

This PMCF study is conducted to confirm the effectiveness and safety of the wound dressing Vliwazell® Pro. The aim of the study is to validate the performance of Vliwazell® Pro within its intended pur...

Detailed Description

Vliwazell® Pro is a flexible and soft superabsorbent wound dressing designed for acute and chronic wounds with moderate to very high levels of exudate (wound fluid). The inner non-woven layer helps ev...

Eligibility Criteria

Inclusion

  • Wound according to indication mentioned in the instructions for use:
  • Superficial acute and chronic wounds with moderate to very high amounts of exudate and that are superficial, in:
  • arterial and venous ulcers
  • diabetic ulcers
  • pressure ulcers
  • post-traumatic wounds
  • post-operative wounds healing by secondary intention
  • skin graft donor sites
  • oncological wounds
  • ulcerating tumors
  • wounds at risk of infection
  • superficial 2nd degree burns
  • lymphatic wounds
  • As secondary dressing on laparotomy wounds and fistulas or for deep wounds when used with appropriate wound filler
  • Patient has full legal capacity
  • Patient is able to understand and provide information
  • Patient has signed the written Informed Consent Form

Exclusion

  • Age \< 18 years
  • Patient with contraindication:
  • Known allergy and/or hypersensitivity to any of the product components.
  • Not for use in tunnel-forming wound pockets, as the product may expand considerably with the absorption of wound exudate.
  • Not for use on dry wounds.
  • Pregnant or lactating women
  • Patients participating in another clinical trial at the time of inclusion
  • Patient not covered by health insurance/social security

Key Trial Info

Start Date :

March 11 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 31 2027

Estimated Enrollment :

208 Patients enrolled

Trial Details

Trial ID

NCT07316556

Start Date

March 11 2024

End Date

January 31 2027

Last Update

January 5 2026

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Wundmanagement

Aachen, Germany

2

MVZ Hausärzte

Brüggen, Germany

3

ORGAMed

Dortmund, Germany

4

Hautklinik

Erlangen, Germany

Post-Marketing Surveillance of Vliwazell® Prowound Dressing | DecenTrialz